Open Access

Erratum to: Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase

Organic and Medicinal Chemistry Letters20133:12

https://doi.org/10.1186/2191-2858-3-12

Received: 5 December 2013

Accepted: 6 December 2013

Published: 17 December 2013

The original article was published in Organic and Medicinal Chemistry Letters 2013 3:8

It has been drawn to the publisher’s attention that this article [1] was inadvertently published with certain omissions. The authors apologize for the omissions in the published article.

The co-authors Nicolas Sluis-Cremer and Brian D. Herman, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA have now been added as co-authors.

The following sentence has been added to the acknowledgements section: “The research in the N.S.–C laboratory was supported by a grant from the United States of America National Institutes of Health (GM068406)”

Notes

Authors’ Affiliations

(1)
Department of Pharmacy, Birla Institute of Technology & Science
(2)
Department of Pharmaceutical Sciences, Birla Institute of Technology

References

  1. Penta , et al.: Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase. Organic and Medicinal Chemistry Letters 2013, 3: 8. 10.1186/2191-2858-3-8View ArticleGoogle Scholar

Copyright

© Penta et al.; licensee Springer. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.